Interestingly, AML cells can enhance the expression of inhibitory receptors, including TIM-3, thus determining CD4+ T cell exhaustion in vitro (47), and TIM-3 expression on immune cells has been correlated to both a better and a poor prognosis in AML patients (48–50). The gene discussed is HAVCR2; the disease is acute myeloid leukemia.